Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027
... Anticoagulant Drug Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2021-2027. Peptides are a specific ... Read More
-
Osteoporosis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2026, registering a CAGR of 3.4% during the forecast period, 2021-2026. Multiple therapeutic regimens are being followed across the world to find a reliable treatment for COVID-19. Several research studies suggested that apart from drugs ... Read More
-
Global Osteoarthritis Gene Therapy Market Size study, by Site of Injection (Synovium, Cartilage) by Vectors (Non-viral, Retrovirus, Lentivirus, Adenovirus, Adeno-associated virus (AAV), HSV) by end use industries (Hospitals and clinics, Orthopedic Centers, Assisted living Facilities, Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027
... Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027 Global Osteoarthritis Gene Therapy Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Osteoarthritis Therapeutics: Global Markets
... for different types of drugs and therapies used to treat osteoarthritis. Based on anatomy, the osteoarthritis therapeutics market is segmented into knee osteoarthritis, hip osteoarthritis, others (shoulder, hand and small joint osteoarthritis). Based on drug ... Read More
-
Osteoarthritis - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Osteoarthritis Understanding The DelveInsight Osteoarthritis epidemiology report gives a ... Read More
-
Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Erosive Hand Osteoarthritis Understanding The ... Read More
-
Osteoporosis - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Osteoporosis Understanding The DelveInsight Osteoporosis epidemiology report gives a ... Read More
-
Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Osteoarthritis market report provides current treatment practices, emerging drugs, Osteoarthritis market share of the individual therapies, current and forecasted Osteoarthritis market Size from 2019 to 2032 ... Read More
-
Osteoporosis - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Osteoporosis market report provides current treatment practices, emerging drugs, Osteoporosis market share of the individual therapies, current and forecasted Osteoporosis market Size from 2019 to 2032 ... Read More
-
Post Menopausal Osteoporosis - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Post Menopausal Osteoporosis Understanding The ... Read More
-
Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2030
... Demand Analysis & Opportunity Outlook 2030 Market Overview Fatpos Global has released a report titled Women’s Health Diagnostics Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. ... Read More
-
Knee Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Knee Osteoarthritis market report provides current treatment practices, emerging drugs, Knee Osteoarthritis market share of the individual therapies, current and forecasted Knee Osteoarthritis ... Read More
Research Assistance
